BSE Live
Oct 10, 16:01Prev. Close
2024.50
Open Price
2012.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:57Prev. Close
2026.10
Open Price
2026.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2056.80 (40)
Profit & Loss account of Caplin Point Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 9 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 844.52 | 632.89 | 525.55 | 390.25 | 231.34 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
Revenue From Operations [Net] | 844.52 | 632.89 | 525.55 | 390.25 | 231.34 | |
Total Operating Revenues | 863.20 | 648.69 | 539.84 | 401.65 | 238.72 | |
Other Income | 41.33 | 19.03 | 12.67 | 9.96 | 3.66 | |
Total Revenue | 904.54 | 667.72 | 552.51 | 411.60 | 242.38 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 108.12 | 95.12 | 90.22 | 64.78 | 44.08 | |
Purchase Of Stock-In Trade | 500.14 | 203.73 | 150.35 | 120.00 | 77.76 | |
Operating And Direct Expenses | 3.33 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FGWIP And Stock In Trade | -195.10 | -10.07 | -2.39 | 0.15 | -0.68 | |
Employee Benefit Expenses | 67.76 | 47.11 | 39.14 | 30.81 | 18.47 | |
Finance Costs | 0.32 | 0.06 | 0.06 | 0.13 | 0.11 | |
Depreciation And Amortisation Expenses | 31.62 | 23.43 | 19.00 | 13.30 | 7.48 | |
Other Expenses | 118.89 | 81.47 | 67.75 | 61.49 | 35.11 | |
Total Expenses | 635.07 | 440.84 | 364.13 | 290.66 | 182.33 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 269.46 | 226.88 | 188.38 | 120.95 | 60.05 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 269.46 | 226.88 | 188.38 | 120.95 | 60.05 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 61.84 | 54.86 | 40.55 | 22.56 | 14.31 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 4.35 | 2.66 | |
Deferred Tax | -7.46 | -4.54 | 3.19 | 7.24 | 2.64 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 54.38 | 50.32 | 43.74 | 25.44 | 14.28 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 215.08 | 176.56 | 144.64 | 95.50 | 45.77 | |
Profit/Loss From Continuing Operations | 215.08 | 176.56 | 144.64 | 95.50 | 45.77 | |
Profit/Loss For The Period | 215.08 | 176.56 | 144.64 | 95.50 | 45.77 | |
Minority Interest | -0.08 | 0.01 | 0.15 | 0.11 | 0.00 | |
Consolidated Profit/Loss After MI And Associates | 215.01 | 176.57 | 144.79 | 95.61 | 45.76 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 28.00 | 23.00 | 19.00 | 13.00 | 30.00 | |
Diluted EPS (Rs.) | 28.00 | 23.00 | 19.00 | 13.00 | 30.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 5.29 | 9.07 | |
Tax On Dividend | 0.00 | -0.01 | 0.00 | 1.08 | 1.85 |
28.08.2025
21.08.2025
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
17.06.2025
07.08.2025
Caplin Labs Standalone June 2025 Net Sales at Rs 182.57 crore, down 1.65% Y-o-Y
15.05.2025
Caplin Labs Consolidated March 2025 Net Sales at Rs 502.45 crore, up 10.86% Y-o-Y
15.05.2025
Caplin Labs Standalone March 2025 Net Sales at Rs 173.61 crore, up 24.56% Y-o-Y
07.02.2025
Caplin Labs Consolidated December 2024 Net Sales at Rs 492.96 crore, up 13.19% Y-o-Y